Chemoinformaics analysis of p-Menthane-1,2,4-triol
| Molecular Weight | 188.267 | nRot | 1 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 6 |
| Exact Molecular Weight | 188.141 | nRing | 1 |
| Solubility: LogS | -0.602 | nHRing | 0 |
| Solubility: LogP | 0.586 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 32.4419 |
| nHD | 3 | BPOL | 20.0641 |
| QED | 0.567 |
| Synth | 4.087 |
| Natural Product Likeliness | 2.601 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.061 |
| HIA | 0.018 |
| CACO-2 | -4.364 |
| MDCK | 0.0000187 |
| BBB | 0.986 |
| PPB | 0.232125 |
| VDSS | 1.33 |
| FU | 0.609941 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.29 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.817 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.411 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.197 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.224 |
| CL | 8.657 |
| T12 | 0.572 |
| hERG | 0.021 |
| Ames | 0.025 |
| ROA | 0.035 |
| SkinSen | 0.068 |
| Carcinogencity | 0.017 |
| EI | 0.548 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.842179 |